24
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Prostatic Involvement of a Testicular Lymphoma in a Patient with Myasthenia Gravis on Long-term Azathioprine

, &
Pages 2425-2426 | Published online: 01 Jul 2009

  • Siliman. A.J. Petrie. J. Hazleman, B. and Evans, S. (1988) "Lympohproliferative cancer and other malignancy in patient with rheumatoid arthritis treated with azathioprine a 20 year follow up studyt". Annals of the Rheumaic Diseases 47, 988-992.
  • Greenstein, A.J. Mullin, G.E., G.E. Struchen. J.A., Heimann. T., Janowitz, H.D., Aufes, A.H. Jr. and Sachar. D.B. (1992) "Lymphoma in inflammatory bowel disease". Cancer 69, 119-123.
  • Anderson, L.G. and Talal. N. (1072) "The spectrum of benign to malignant lymphoprofiferation in Sjorgen's syndrome", Clinical and Experimental Immunology 10, 121-199.
  • Cammarata, R.J., Tofnsn, G.P. and Jenson. W.N. (1963) "Systemic rheumatic disease and malignant lymphoma", Archives of Internal Medicine 3, 330-337.
  • Penn, I, (1978) "Malignancies associated with immunosuppressive or cytotoxic therapy". Surgery 83, 492-502.
  • Levo, Y., Knott, E. and Atsmon, A. (1955) "Association between myasthenia gravis and malignant lymphoma". European Neurology 13, 245-250.
  • Hohlfeld, R., Michels. M., Heininger. K., Besinger. U. and Toyka, K.V. (1988) "Azathiprine toxity during long-term immuno-suppression of generalized myasthenia gravis". Neurology 38(2), 258-261.
  • Shahab, N. and Doll. D.C. (1999) "Testicular lymphoma". Seminars in Oncology 26(3). 259-269.
  • Crellin A.M., Hudson. B.V., Bennett M.H., Harland, S. and Hudson. G.V. (1993) "Non-Hodgkin's lymphoma of the tests", Radiotherapy and Oncology 27, 99-106.
  • Parziani, S., Rosi. P., Sidoni, and Porena. M. (1993) "Urinary retention due to prostatic involvement in testicular lymphoma- a case report". Acta Urologica Belgica 61(3). 33-37.
  • Jiménez-Hernández M., López-Guillermo. A., Cobo, F., et al. (2002) "Bladder involvement of diffuse large B-cell lymphoma diagnosed by a cytolocical study of urine", Leukemia and Lymphoma 43(1), 187-189.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.